Gilead analysis shows remdesivir reduced coronavirus death risk, more studies needed

Gilead Sciences Inc said on Friday an analysis showed its antiviral remdesivir helped reduce the risk of death in severely ill Covid-19 patients, but cautioned that rigorous clinical trials were neede...